Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON36747
NL-OMON36747
Completed
N/A

A ONE-WAY DRUG DRUG INTERACTION STUDY TO ASSESS THE EFFECT OF EFAVIRENZ ON THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF BMS-790052 IN HEALTHY SUBJECTS - BMS-790052/efavirenz drug-drug interaction study

Bristol-Myers Squibb0 sites17 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHepatitis Cviral liver inflammation10047438

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hepatitis C
Sponsor
Bristol-Myers Squibb
Enrollment
17
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age: 18\-49 years, inclusive
  • •BMI: 18\.0 \- 32\.0 kg/m2, inclusive
  • •Females should be post menopausal or surgically sterile

Exclusion Criteria

  • •Suffering from: hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 90 days from the start of the study or in case of donating more than 1 liter of blood (men) or more than 1\.5 liter of blood (women) in the 10 months prior the start of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
A One-Way Drug-Drug Interaction Study to Assess the Effect of Ritonavir-boosted Atazanavir on the Pharmacokinetics, Safety and Tolerability of BMS-790052 in Healthy SubjectsHepatitis Cviral liver inflammation10047438
NL-OMON36726Bristol-Myers Squibb14
Not Yet Recruiting
Phase 1
A Phase 1 Drug-Drug Interaction Study to Assess the Interaction Potential of NB-4746 on CYP1A2 and CYP3A4 Substrates in Healthy Volunteers
ACTRN12624001072505ura Bio18
Not Yet Recruiting
N/A
A phase 1 study to evaluate drug-drug interactions of Bojungikgitang with Clopidogrel, Atorvastatin, and Fimasartan/Amlodipine in healthy adult volunteers
KCT0007296Kyunghee University-industry Cooperation Foundation42
Completed
N/A
A Drug-Drug Interaction, Safety and Efficacy Study With JNJ-56021927 (ARN-509) and Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancerprostate cancer10036958
NL-OMON44408Johnson & Johnson Pharmaceutical10
Active, Not Recruiting
N/A
Drug interaction study with thyroid hormone and zinc preparation in healthy volunteersHypothyroidismNutritional, Metabolic, Endocrine
ISRCTN73459064niversity Hospital of Zurich15